XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2021 40,851,945        
Balance at Dec. 31, 2021 $ 4,000 $ 91,025,000 $ (49,759,000) $ (6,000) $ 41,264,000
Common shares issued upon exercise of stock options (in shares) 50,000        
Common shares issued upon exercise of stock options $ 0 75,000 0 0 75,000
Share-based compensation expense $ 0 1,756,000 0 0 1,756,000
Common shares issued upon vesting of restricted stock units (in shares) 90,216        
Net loss for the period $ 0 0 (10,217,000) 0 (10,217,000)
Net unrealized gain (loss) on short-term investments $ 0 0 0 (11,000) (11,000)
Common shares issued for services (in shares) 0        
Common shares issued for services $ 0 0 0 0 0
Balance (in shares) at Jun. 30, 2022 40,992,161        
Balance at Jun. 30, 2022 $ 4,000 92,856,000 (59,976,000) (17,000) 32,867,000
Balance (in shares) at Mar. 31, 2022 40,951,197        
Balance at Mar. 31, 2022 $ 4,000 92,129,000 (55,191,000) (29,000) 36,913,000
Share-based compensation expense $ 0 727,000 0 0 727,000
Common shares issued upon vesting of restricted stock units (in shares) 40,964        
Net loss for the period $ 0 0 (4,785,000) 0 (4,785,000)
Net unrealized gain (loss) on short-term investments $ 0 0 0 12,000 12,000
Balance (in shares) at Jun. 30, 2022 40,992,161        
Balance at Jun. 30, 2022 $ 4,000 92,856,000 (59,976,000) (17,000) 32,867,000
Balance (in shares) at Dec. 31, 2022 41,175,993        
Balance at Dec. 31, 2022 $ 4,000 94,333,000 (67,376,000) 94,000 $ 27,055,000
Common shares issued upon exercise of stock options (in shares) 250       250
Common shares issued upon exercise of stock options $ 0 0 0 0 $ 0
Share-based compensation expense $ 0 1,849,000 0 0 1,849,000
Common shares issued upon vesting of restricted stock units (in shares) 734,444        
Common shares issued upon vesting of restricted stock units $ 0 0 0 0 0
Net loss for the period 0 0 (9,035,000) 0 (9,035,000)
Settlement – US Treasury bills $ 0 0 0 (94,000) (94,000)
Net unrealized gain (loss) on short-term investments         0
Balance (in shares) at Jun. 30, 2023 41,910,687        
Balance at Jun. 30, 2023 $ 4,000 96,182,000 (76,411,000) 0 19,775,000
Balance (in shares) at Mar. 31, 2023 41,270,300        
Balance at Mar. 31, 2023 $ 4,000 94,961,000 (71,404,000) 0 23,561,000
Common shares issued upon exercise of stock options (in shares) 0        
Common shares issued upon exercise of stock options $ 0 0 0 0 0
Share-based compensation expense $ 0 1,221,000 0 0 1,221,000
Common shares issued upon vesting of restricted stock units (in shares) 640,387        
Common shares issued upon vesting of restricted stock units $ 0 0 0 0 0
Net loss for the period $ 0 0 (5,007,000) 0 (5,007,000)
Net unrealized gain (loss) on short-term investments         0
Balance (in shares) at Jun. 30, 2023 41,910,687        
Balance at Jun. 30, 2023 $ 4,000 $ 96,182,000 $ (76,411,000) $ 0 $ 19,775,000